Month: May 2025
-
Advancing Research and Care at Alzheimer Day
Patients and families joined faculty, students and trainees on May 15 for Alzheimer Day, an annual event hosted by the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease to showcase dementia and aging research conducted throughout Northwestern and bring those discoveries to the community.
-
Celebrating the MD Class of 2025
Feinberg honored the MD Class of 2025 during the medical school’s 166th commencement ceremony held in the Aon Grand Ballroom at Navy Pier on May 19.
-
Celebrating Honors Day 2025
Fourth-year medical students and faculty members were recognized for academic and clinical excellence during Feinberg’s Honors Day, held on May 16 in the Hughes Auditorium.
-
Body’s Own Cannabinoids May Be Key to Reducing Excessive Fear Responses
Specific cannabinoids produced by the human body may help to quell excessive fear responses in people with post-traumatic stress disorder and anxiety, according to a Northwestern Medicine-led study published in the Journal of Clinical Investigation.
-
Medical Student Investigates New Approach to Measuring Cardiovascular Disease Risk
Jim Walker, a third-year student in Feinberg’s MD/MBA program, was the lead author of a recent study published in JAMA Cardiology, which found that using the American Heart Association’s “Life’s Essential 8” cardiovascular health paradigm to measure cumulative cardiovascular health may be an effective strategy for identifying young adults at higher risk of cardiovascular disease.
-
New Wearable Tech Simulates Realistic Touch
In a study published in Science, Northwestern University engineers have unveiled a new technology that creates precise movements to mimic complex sensations including pressure, vibration and stretching.
-
Cardiac Biomarkers Don’t Predict Outcomes of Valve Replacements
Measuring standard cardiac biomarkers did not predict whether patients with asymptomatic severe aortic stenosis would benefit from nonsurgical aortic valve replacement, according to a recent study published in Circulation.
-
Pioneering New Techniques in the Fight Against Alzheimer’s Disease
More than seven million Americans aged 65 years and older currently live with Alzheimer’s disease, according to recent estimates from the Alzheimer’s Association. As the prevalence of the disease increases, so does the need for research that identifies underlying mechanisms of disease to enhance the effectiveness of current therapies and inform new therapeutic strategies.
-
New Biomarkers Needed to Evaluate Heart Failure Risk Post-Pregnancy
Biomarkers used to predict heart failure risk in the general population may be ineffective for assessing risk after pregnancies complicated by hypertension or diabetes, according to a study published in JAMA Cardiology.
-
The Antibiotic That Takes the Bite Out of Lyme
A new Northwestern study shows piperacillin, an antibiotic, effectively cured mice of Lyme disease at a dose 100 times smaller than the effective dose of doxycycline, the current gold-standard treatment.